MedTrace Logo

To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100

NCT05684718 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2023-11-21

No results posted yet for this study

Summary

Phase I clinical study to evaluate the effect of multiple doses of itraconazole on the pharmacokinetics of BV100 in healthy volunteers.

Conditions

Interventions

DRUG

BV100 (300 mg)

Intravenous solution

DRUG

Itraconazole 200 mg

Oral solution

Sponsors & Collaborators

  • Clinical Research Units Hungary

    collaborator OTHER

  • BioVersys AG

    lead INDUSTRY

Principal Investigators

  • Lisa Husband, MD · BioVersys SAS

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-09-30
Completion
2023-10-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05684718 on ClinicalTrials.gov